G
Glenmark Pharmaceuticals
GLENMARK Share Price
Healthcare2,068.90
as on 09 Mar 2026 at 10:55
Market Cap
₹58,385 Cr
PE Ratio
56.20
ROCE
15.93%
GLENMARK Fundamentals
Company Valuation
Market Cap (₹ Cr.)
58,385
PE Ratio
56.20
PB Ratio
6.25
Dividend Yield
0.12%
ROE
11.83%
ROCE
15.93%
Book Value (₹)
339.54
Face Value (₹)
1.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 46.65% | 46.65% | 46.65% | 46.65% | 46.65% |
| Domestic Institutional Investors (DII) | 13.85% | 14.60% | 17.64% | 18.61% | 20.09% |
| Foreign Institutional Investors (FII) | 23.51% | 23.16% | 20.62% | 20.73% | 19.20% |
| Public Investors | 12.65% | 12.32% | 11.69% | 10.81% | 10.77% |
| Government | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLENMARK Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
532296
NSE Scrip Name
GLENMARK
ISIN
INE935A01035



